Related Experiment Video
Updated: Jul 10, 2026
14:13
Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory
Published on: January 1, 2018
Cytofluorometric analysis for estrogen receptors using fluorescent estrogen probes
Cytometry
|September 1, 1983
Summary
Developing a rapid estrogen receptor (ER) assay for breast cancer is crucial. Coumestrol shows promise as a fluorescent probe for ER detection via flow cytometry, offering a faster alternative to traditional methods.
Area of Science:
- Biochemistry
- Oncology
- Analytical Chemistry
Background:
- Estrogen receptor (ER) analysis is vital for breast cancer prognosis and hormone therapy prediction.
- Current ER assays are time-consuming and labor-intensive, necessitating faster methods.
Purpose of the Study:
- To evaluate fluorescent estrogen derivatives as potential probes for rapid ER measurement in breast cancer.
- To assess the feasibility of using flow cytometry for ER quantification.
Main Methods:
- Synthesized and analyzed fluorescein-labeled estrogen probes and coumestrol for ER binding affinity and fluorescence.
- Utilized competition studies and High-Performance Liquid Chromatography (HPLC) for compound analysis.
- Performed flow cytometry on viable cell suspensions to measure fluorescent probe uptake.
Main Results:
- Fluorescein-labeled estrogen probes suffered from low ER affinity and purity issues.
- A peptide-linked fluoresceinated estrogen showed no cellular uptake or ER binding.
- Coumestrol, a pure plant estrogen, exhibited good ER binding affinity (Ka = 6 X 10(8) M-1) and specific cellular uptake.
Conclusions:
- Coumestrol demonstrates potential as a fluorescent probe for ER detection in breast cancer.
- Flow cytometry with coumestrol offers a rapid and specific method for ER analysis, potentially improving patient management.
